These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 24582968)

  • 1. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
    Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
    Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
    Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
    Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
    Mo H; Elson CE
    Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury.
    Eftekharpour E; Nagakannan P; Iqbal MA; Chen QM
    Curr Mol Pharmacol; 2017; 10(2):141-151. PubMed ID: 26758952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mevalonate Pathway and Human Cancers.
    Bathaie SZ; Ashrafi M; Azizian M; Tamanoi F
    Curr Mol Pharmacol; 2017; 10(2):77-85. PubMed ID: 26758953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early embryonic lethality caused by targeted disruption of the 3-hydroxy-3-methylglutaryl-CoA reductase gene.
    Ohashi K; Osuga J; Tozawa R; Kitamine T; Yagyu H; Sekiya M; Tomita S; Okazaki H; Tamura Y; Yahagi N; Iizuka Y; Harada K; Gotoda T; Shimano H; Yamada N; Ishibashi S
    J Biol Chem; 2003 Oct; 278(44):42936-41. PubMed ID: 12920113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
    Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
    J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
    Longo J; Mullen PJ; Yu R; van Leeuwen JE; Masoomian M; Woon DTS; Wang Y; Chen EX; Hamilton RJ; Sweet JM; van der Kwast TH; Fleshner NE; Penn LZ
    Mol Metab; 2019 Jul; 25():119-130. PubMed ID: 31023626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.
    Pandyra AA; Mullen PJ; Goard CA; Ericson E; Sharma P; Kalkat M; Yu R; Pong JT; Brown KR; Hart T; Gebbia M; Lang KS; Giaever G; Nislow C; Moffat J; Penn LZ
    Oncotarget; 2015 Sep; 6(29):26909-21. PubMed ID: 26353928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
    Henneman L; van Cruchten AG; Kulik W; Waterham HR
    Biochim Biophys Acta; 2011 Apr; 1811(4):227-33. PubMed ID: 21237288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase.
    Maciejak A; Leszczynska A; Warchol I; Gora M; Kaminska J; Plochocka D; Wysocka-Kapcinska M; Tulacz D; Siedlecka J; Swiezewska E; Sojka M; Danikiewicz W; Odolczyk N; Szkopinska A; Sygitowicz G; Burzynska B
    BMC Biotechnol; 2013 Aug; 13():68. PubMed ID: 24128347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
    Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
    Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Mevalonate Pathway in Cancer.
    Juarez D; Fruman DA
    Trends Cancer; 2021 Jun; 7(6):525-540. PubMed ID: 33358111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin therapy inhibits fatty acid synthase via dynamic protein modifications.
    Trub AG; Wagner GR; Anderson KA; Crown SB; Zhang GF; Thompson JW; Ilkayeva OR; Stevens RD; Grimsrud PA; Kulkarni RA; Backos DS; Meier JL; Hirschey MD
    Nat Commun; 2022 May; 13(1):2542. PubMed ID: 35538051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia.
    Bi X; Baudry M; Liu J; Yao Y; Fu L; Brucher F; Lynch G
    J Biol Chem; 2004 Nov; 279(46):48238-45. PubMed ID: 15364922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy.
    Osaki Y; Nakagawa Y; Miyahara S; Iwasaki H; Ishii A; Matsuzaka T; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Sone H; Ohashi K; Ishibashi S; Yamada N; Shimano H
    Biochem Biophys Res Commun; 2015 Oct; 466(3):536-40. PubMed ID: 26381177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Risk Polymorphisms Associated with the Molecular Function of Human HMGCR Gene Infer the Inhibition of Cholesterol Biosynthesis.
    Das KC; Hossain MU; Moniruzzaman M; Salimullah M; Akhteruzzaman S
    Biomed Res Int; 2022; 2022():4558867. PubMed ID: 35707384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
    Zhou Q; Liao JK
    Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application.
    Jiao X; Ashtari N; Rahimi-Balaei M; Chen QM; Badbezanchi I; Shojaei S; Marzban A; Mirzaei N; Chung S; Guan T; Li J; Vriend J; Mehr SE; Kong J; Marzban H
    Curr Mol Pharmacol; 2017; 10(2):115-140. PubMed ID: 26758948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.